BioLife Solutions, Inc. Equity Method Investments
BioLife Solutions, Inc. (BLFS) had Equity Method Investments of $0 as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:EquityMethodInvestments · last filed 2026-02-26
- 2025-12-31: Equity Method Investments $0.00.
- 2025-09-30: Equity Method Investments $0.00.
- 2025-06-30: Equity Method Investments $0.00.
- 2025-03-31: Equity Method Investments $995.00K.
| Period end | Equity Method Investments | Equity Method Investments as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $995.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $995.00K 10-K · filed 2026-02-26 | |
| 2023-12-31 | $5.07M 10-K · filed 2025-03-03 | |
| 2020-09-30 | $54.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $41.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $27.00K 10-Q · filed 2020-05-29 | |
| 2019-09-30 | $1.00M 10-K · filed 2020-05-15 | |
| 2019-06-30 | $6.10M 10-K · filed 2020-05-15 | |
| 2019-03-31 | $6.32M 10-K · filed 2020-05-15 | |
| 2018-12-31 | $6.55M 10-K · filed 2020-05-15 | |
| 2018-09-30 | $6.86M 10-K · filed 2020-05-15 | $6.86M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.90M 10-K · filed 2020-05-15 | $1.90M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $926.00K 10-K · filed 2020-05-15 | $926.36K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $1.07M 10-K · filed 2019-03-15 | $1.07M 10-Q · filed 2018-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |